Cytokinetics CYTK Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Cytokinetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytokinetics's total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytokinetics's total operating expenses?
- Cytokinetics (CYTK) reported total operating expenses of $202.97M in Q1 2026.
- How has Cytokinetics's total operating expenses changed year-over-year?
- Cytokinetics's total operating expenses increased by 29.1% year-over-year, from $157.21M to $202.97M.
- What is the long-term trend for Cytokinetics's total operating expenses?
- Over 4 years (2021 to 2025), Cytokinetics's total operating expenses has grown at a 28.5% compound annual growth rate (CAGR), from $256.74M to $700.3M.
- What does total operating expenses mean?
- The sum of all costs required to operate the business on a daily basis.
- How do you interpret total operating expenses?
- An increase indicates higher operational investment or rising costs, which must be balanced against revenue growth to maintain financial sustainability.
- How does total operating expenses compare across companies?
- Standard metric for evaluating operational efficiency across all sectors.